Agios Pharmaceuticals (AGIO) Change in Inventory (2018 - 2026)

Agios Pharmaceuticals has reported Change in Inventory for 8 years, with the latest figure at $2.2 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory rose 8.95% year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2026 stood at $5.5 million (down 16.11% YoY), and the FY2025 full-year result was $5.3 million, down 37.89% from the prior year.
• Change in Inventory for Q1 2026 stood at $2.2 million, up from $886000.0 in the prior quarter.
• The five-year high for Change in Inventory was $4.3 million in Q2 2023, with the low at $867000.0 in Q2 2024.
• Historically, Change in Inventory has averaged $2.1 million across 5 years, with a median of $1.8 million in 2023.
• Annual changes were most pronounced in 2023 — Change in Inventory surged 172.83% — and 2024, when it sank 79.82%.
• Agios Pharmaceuticals' Change in Inventory stood at $3.3 million in 2022, then slumped by 45.66% to $1.8 million in 2023, then sank by 34.13% to $1.2 million in 2024, then decreased by 25.36% to $886000.0 in 2025, then jumped by 144.58% to $2.2 million in 2026.
• The last three Change in Inventory figures came in at $2.2 million (Q1 2026), $886000.0 (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.